News
IPDQF
0.0039
NaN%
--
ImpediMed Discloses Director Share Transfer Following Financial Settlement
TipRanks · 3d ago
Impedimed Seeks ASX Quotation for Additional Ordinary Shares
TipRanks · 10/14 03:37
ImpediMed Director Erik Anderson Significantly Increases Shareholding
TipRanks · 09/30 04:08
ImpediMed Keeps Existing Structure for Attaching and Follow-On Options After ASX Ruling
TipRanks · 09/23 23:16
ImpediMed Sets November Date for 2026 AGM and Board Nomination Deadline
TipRanks · 09/11 02:17
Analysts Offer Insights on Healthcare Companies: Impedimed Limited (OtherIPDQF) and Intuitive Surgical (ISRG)
TipRanks · 08/31 00:40
Analysts Offer Insights on Healthcare Companies: Polynovo (OtherCALZF), Clinuvel Pharmaceuticals (OtherCLVLF) and Impedimed Limited (OtherIPDQF)
TipRanks · 08/27 23:40
ImpediMed lodges 2026 Corporate Governance Statement and Appendix 4G
TipRanks · 08/27 01:20
ImpediMed grows revenue but posts deeper loss as asset backing erodes
TipRanks · 08/27 01:20
ImpediMed Wins FDA Nod for SOZO Sarcopenia Risk Assessment
TipRanks · 08/19 00:20
ImpediMed flags ASX rule breaches, tightens capital compliance controls
TipRanks · 08/13 11:41
Impedimed Options Lapse Trims Potential Share Dilution
TipRanks · 08/06 08:26
Impedimed Limited (IPDQF) Receives a Buy from Bell Potter
TipRanks · 07/29 02:05
Analysts Are Bullish on These Healthcare Stocks: Telix Pharmaceuticals (TLPPF), Impedimed Limited (IPDQF)
TipRanks · 07/29 00:10
ImpediMed Releases Investor Presentation on Q4 FY26 Results
TipRanks · 07/27 23:09
ImpediMed lifts Q4 revenue as SOZO footprint and BCRL reimbursement expand
TipRanks · 07/27 23:09
ImpediMed schedules Q4 FY26 cash flow release and investor webinar
TipRanks · 07/23 00:07
Impedimed director boosts shareholding via equity‑based fees
TipRanks · 07/03 05:58
Impedimed Director Boosts Indirect Holding Through Share-Based Fees
TipRanks · 07/03 05:57
ImpediMed director boosts stake through equity-based fee payment
TipRanks · 07/03 05:47
More
Webull provides a variety of real-time IPDQF stock news. You can receive the latest news about Impedimed through multiple platforms. This information may help you make smarter investment decisions.
About IPDQF
ImpediMed Limited is an Australia-based medical technology company. The Company uses bioimpedance spectroscopy (BIS) technology to generate data to maximize patient health. The Company designs and manufactures medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the noninvasive clinical assessment and monitoring of fluid status and tissue composition. The Company’s SOZO Digital Health Platform is a Food and Drug Administration (FDA)-cleared bioimpedance spectroscopy (BIS) solution for the clinical assessment of lymphedema. Its SOZO Applications include L-Dex Analysis for Lymphedema, BodyComp Analysis, Segmental BodyComp Analysis, and HF-Dex Analysis for Heart Failure. Its product SFB7 measures fluid status and tissue composition for clinical and research applications. Its ImpediVET is a single-channel, tetrapolar bioimpedance spectroscopy (BIS) device that measures fluid status and tissue composition for veterinary applications.